Breast cancer cryoablation in combination with anti-CTLA-4 increases T cell activation in a murine tumor model

被引：0
|
作者：
de Miranda, Flavia Sardela [1 ]
Babcock, Rachel [1 ]
Castro, Maribel [1 ]
Khan, Sonia Y. [1 ]
Roach, Carsen [2 ]
Hintelmann, Thomas [1 ]
Furr, Kathryn [1 ]
Lee, Chang H. [2 ]
Boligala, Geetha P. [1 ]
Rasha, Fahmida [1 ]
Brandi, Luis [1 ]
Gill, Harvinder S. [2 ]
Pruitt, Kevin [1 ]
Rahman, Rakhshanda L. [1 ]
机构：
[1] Texas Tech Univ Hlth Sci Ctr, Lubbock, TX USA
[2] Texas Tech Univ, Lubbock, TX USA
来源：
CANCER IMMUNOLOGY RESEARCH | 2022年 / 10卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B18
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Effects of anti-CTLA-4 and anti-PD-1 on memory T-cell differentiation and resistance to tumor relapse.
    Mok, Stephen
    Duffy, Colm R.
    Anang, Nana-Ama A.
    Allison, James P.
    CANCER RESEARCH, 2020, 80 (19) : 42 - 42
  • [32] A novel anti-CTLA-4 antibody with potent anti-tumor activity emerged using humanized CTLA-4 mouse model
    Guo, Chaoshe
    Yang, Yi
    Li, Zhihong
    Li, Yanan
    Chen, Yunyun
    CANCER RESEARCH, 2020, 80 (16)
  • [33] Combination of PV-10 immunochemoablation and systemic anti-CTLA-4 antibody therapy in murine models of melanoma
    Wachter, Eric A.
    Blair, Savannah
    Singer, Jamie
    Dees, Craig
    CANCER RESEARCH, 2013, 73 (08)
  • [34] Combination PancVAX neo-epitope vaccine with anti-CTLA-4 and anti-PD-1 antibodies enhances infiltration of cytotoxic T cells and mitigates T cell exhaustion in a murine model of pancreatic ductal adenocarcinoma
    Mitchell, Jacob T.
    Huff, Amanda
    Davis-Marcisak, Emily
    Chen, Fangluo
    Armstrong, Todd D.
    Kagohara, Luciane T.
    Leatherman, James
    Wang, Rulin
    Yegnasubramanian, Srinivasan
    Jaffee, Elizabeth M.
    Fertig, Elana J.
    Zaidi, Neeha
    CANCER RESEARCH, 2023, 83 (07)
  • [35] Dissecting the therapeutic effects of anti-CTLA-4 and ADT in a murine hormone-sensitive prostate cancer
    Subudhi, Sumit Kumar
    Montalvo-Ortiz, Welby
    Scher, Howard I.
    Allison, James Patrick
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [36] ENHANCED ANTI-TUMOR EFFECTS OF ANTI-CTLA-4 ANTIBODY AND ANTI-PD-1 ANTIBODY TO KIDNEY CANCER MODEL IN MICE
    Motoshima, Takanobu
    Komohara, Yoshihiro
    Hasita, Horlad
    Kawano, Yoshiaki
    Wada, Yoshihiro
    Takeya, Motohiro
    Eto, Masatoshi
    JOURNAL OF UROLOGY, 2014, 191 (04): : E372 - E373
  • [37] Effects of corticosteroids on tumor immunity induced by anti-CTLA-4 mAb therapy in a mouse model
    Maeda, Yuka
    Kato, Takuma
    Wang, Linan
    Muraoka, Daisuke
    Sato, Eiichi
    Wolchok, Jedd D.
    Old, Lloyd J.
    Shiku, Hiroshi
    Nishikawa, Hiroyoshi
    CANCER RESEARCH, 2010, 70
  • [38] Targeted delivery of anti-CTLA-4 antibody downregulates T cell function in vitro and in vivo
    Rao, S
    Vasu, C
    Martinez, O
    Kaithamana, S
    Prabhakar, BS
    Holterman, MJ
    CLINICAL IMMUNOLOGY, 2001, 101 (02) : 136 - 145
  • [39] An oral cancer vaccine using Bifidobacterium vector augments combination of anti-PD-1 and anti-CTLA-4 antibodies in mouse renal cell carcinoma model
    Hideto Ueki
    Koichi Kitagawa
    Mako Kato
    Shihoko Yanase
    Yasuyoshi Okamura
    Yukari Bando
    Takuto Hara
    Tomoaki Terakawa
    Junya Furukawa
    Yuzo Nakano
    Masato Fujisawa
    Toshiro Shirakawa
    Scientific Reports, 13
  • [40] Suppressing T cell motility induced by anti-CTLA-4 monotherapy improves antitumor effects
    Ruocco, Maria Grazia
    Pilones, Karsten A.
    Kawashima, Noriko
    Cammer, Michael
    Huang, Julie
    Babb, James S.
    Liu, Mengling
    Formenti, Silvia C.
    Dustin, Michael L.
    Demaria, Sandra
    JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (10): : 3718 - 3730
12345